Gabriella Abruzzo
Climate Projects Officer, Health Care Without Harm Europe (HCWH)

Carin A. Uyl-de Groot (1966) is Professor of Health Technology Assessment at Erasmus University Rotterdam and director of the Institute for Medical Technology Assessment (iMTA b.v.). Since 2014, she has been a member of the Dutch Committee on Expensive Cancer Drugs (CieBOM) and, since 2015, of the Dutch Health Council.
Her research focuses on cost-effectiveness and outcomes studies, with patient perspectives consistently integrated as a crucial element. She is principal investigator for disease registries and international projects, including ASCERTAIN under Horizon Europe and NIH-supported initiatives, ensuring that patient-reported outcomes are part of the evidence base guiding healthcare decisions.
Uyl-de Groot supervises numerous PhD students and contributes as editor and reviewer to several leading journals. Her work has been published in Lancet Oncology, Nature Reviews Clinical Oncology, Journal of Clinical Oncology, JAMA, BMJ, and Blood, and presented at major international conferences. Her influential papers, including a novel drug pricing model in Nature Reviews and an analysis of disparities in access to cancer drugs in Cancers, have received wide recognition. Across all projects, she emphasizes that meaningful evaluation of healthcare innovations requires not only clinical and economic evidence but also the inclusion of patient voices.
Climate Projects Officer, Health Care Without Harm Europe (HCWH)
Capacity Building Officer & Patient Advocate, European Patients' Forum (EPF)
President, European Federation of Neurological Associations (EFNA)
President, Standing Committee of European Doctors (CPME)
Secretary General, European Alcohol Policy Alliance
President & CEO, The Ehlers-Danlos Society
Director of Preference Research and Global Lead of the Patient-Centered Outcomes, OPEN Health
MD, Board Member, European Patients' Forum (EPF)
Senior Manager IVD, MedTech Europe
Executive Director, European Regional and Local Health Authorities (EUREGHA)
Researcher & Populariser, Vaccination et Lien Social (VLS)
Senior Research Officer, Swedish Research Council
Chair, Council of Europe Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO)
Executive Director, EUPATI
Movement Health, Executive Director
Deputy Administrator General, National Institute for Health and Disability Insurance (NIHDI)
President, European Patients' Forum (EPF)
Board Chair, Czech National Association of Patient Organizations (NAPO) & Board Member, European Patients' Forum (EPF)
Director for Executive Education in Government, Health and Non Profit Division, SDA Bocconi
Implementation Scientist & Qualitative Researcher, University of Antwerp
Policy Officer, DG SANTE, European Commission
Youth Group Member, European Patients' Forum (EPF)
President, European Liver Patient Association (ELPA)
Head of Government Affairs, EMEA MedTech, Johnson & Johnson
Professor, Sorbonne Université
Regional Director, WHO/Europe
Youth Group Member, European Patients' Forum (EPF)
Director for Digital, EU4Health and Health systems modernisation, DG SANTE, European Commission
Director General, EFPIA
IMMUcan scientific lead
Senior Economist, Organisation for Economic Co-operation and Development (OECD)
Executive Director, Biomed Alliance
SVP International, Butterfly Network Inc
Director General, AESGP
Vice President Corporate Affairs, Shionogi Europe
Public Affairs Director, OM Pharma
Chief Medical Officer, European Medicines Agency
Prof Dr, Erasmus University Rotterdam
Head of Unit, Policy and Coordination, HERA, European Commission
More speakers Announced soon
Stay Tuned!
CEO, Millwater Partners
Chief Partnership Officer, The Synergist
Regional Innovation Lead, NHS Greater Glasgow and Clyde Board (NHSGGC)
Policy Officer, European Patients' Forum (EPF)
PhD, MBA. Secretary of the Board, HTAi
Policy Officer, European Patients' Forum (EPF)
Head of Policy, European Patients' Forum (EPF)
Interim Executive Director, European Patients' Forum (EPF)
More moderators Announced soon
Stay Tuned!